U
Navidea Biopharmaceuticals, Inc. NAVB
$0.0001 $0.000.00%
Recommendation
--
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2023 06/30/2023
Revenue -- --
Total Other Revenue -- --
Total Revenue -- --
Cost of Revenue -- --
Gross Profit -- --
SG&A Expenses -1.49% 14.47%
Depreciation & Amortization -- --
Other Operating Expenses -- --
Total Operating Expenses -12.21% 0.24%
Operating Income 12.21% -0.24%
Income Before Tax -61.88% 5.63%
Income Tax Expenses -- --
Earnings from Continuing Operations -61.88% 5.63%
Earnings from Discontinued Operations -- --
Extraordinary Item & Accounting Change -- --
Minority Interest in Earnings -- --
Net Income -137.39% 508.58%
EBIT 12.21% -0.24%
EBITDA 12.34% -0.26%
EPS Basic -118.81% 367.04%
Normalized Basic EPS 60.45% -25.53%
EPS Diluted -118.81% 367.04%
Normalized Diluted EPS 60.45% -25.53%
Average Basic Shares Outstanding 105.97% 47.74%
Average Diluted Shares Outstanding 105.97% 47.74%
Dividend Per Share -- --
Payout Ratio -- --
Weiss Ratings